PT76595A - Procede de preparation de benzoazacycloalkyl-spiro-imidazolidines - Google Patents
Procede de preparation de benzoazacycloalkyl-spiro-imidazolidinesInfo
- Publication number
- PT76595A PT76595A PT76595A PT7659583A PT76595A PT 76595 A PT76595 A PT 76595A PT 76595 A PT76595 A PT 76595A PT 7659583 A PT7659583 A PT 7659583A PT 76595 A PT76595 A PT 76595A
- Authority
- PT
- Portugal
- Prior art keywords
- benzoazacycloalkyl
- imidazolidines
- spiro
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8207203A FR2525603A1 (fr) | 1982-04-27 | 1982-04-27 | Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT76595A true PT76595A (fr) | 1983-05-01 |
| PT76595B PT76595B (fr) | 1986-01-21 |
Family
ID=9273425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT76595A PT76595B (fr) | 1982-04-27 | 1983-04-26 | Procede de preparation de benzoazacycloalkyl-spiro-imidazolidines |
Country Status (22)
| Country | Link |
|---|---|
| JP (1) | JPS5910584A (fr) |
| KR (1) | KR840004428A (fr) |
| AT (1) | ATA125383A (fr) |
| AU (1) | AU1395383A (fr) |
| BE (1) | BE896572A (fr) |
| DD (1) | DD209833A5 (fr) |
| DE (1) | DE3315106A1 (fr) |
| DK (1) | DK183583A (fr) |
| ES (1) | ES521895A0 (fr) |
| FR (1) | FR2525603A1 (fr) |
| GB (1) | GB2133401B (fr) |
| GR (1) | GR78481B (fr) |
| IL (1) | IL68497A0 (fr) |
| IT (1) | IT1167123B (fr) |
| LU (1) | LU84770A1 (fr) |
| MA (1) | MA19783A1 (fr) |
| NL (1) | NL8301476A (fr) |
| NO (1) | NO831473L (fr) |
| OA (1) | OA07412A (fr) |
| PT (1) | PT76595B (fr) |
| SE (1) | SE8302347L (fr) |
| ZA (1) | ZA832927B (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4927831A (en) * | 1988-10-20 | 1990-05-22 | American Home Products | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| AU617541B2 (en) * | 1988-10-20 | 1991-11-28 | Wyeth | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
| EP2332920A3 (fr) | 2003-06-17 | 2011-12-21 | Arena Pharmaceuticals, Inc. | Procédés de préparation de 3-benzazepines |
| PL2332921T3 (pl) | 2003-06-17 | 2016-08-31 | Arena Pharm Inc | Chlorowodorek 8-chloro-1-metylo-2,3,4,5-tetrahydro-1H-3-benzazepiny |
| CN101084193B (zh) | 2004-12-21 | 2011-12-07 | 艾尼纳制药公司 | (r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓盐酸盐的晶型 |
| SG158168A1 (en) | 2004-12-23 | 2010-01-29 | Arena Pharm Inc | 5ht2c receptor modulator compositions and methods of use |
| JP5199997B2 (ja) | 2006-04-03 | 2013-05-15 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンズアゼピンおよびこれに関連する中間体を調製するためのプロセス |
| ES2522587T3 (es) | 2006-12-05 | 2014-11-17 | Arena Pharmaceuticals, Inc. | Procesos para preparar (R)-8-cloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzacepina e intermedios de la misma |
| US8822727B2 (en) | 2008-03-04 | 2014-09-02 | Arena Pharmaceuticals, Inc. | Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine |
| WO2010148207A2 (fr) | 2009-06-18 | 2010-12-23 | Arena Pharmaceuticals, Inc. | Procédés pour la préparation d'agonistes du récepteur 5-ht2c |
| KR20130112848A (ko) | 2010-06-02 | 2013-10-14 | 아레나 파마슈티칼스, 인크. | 5-ｈｔ2ｃ 수용체 아고니스트의 제조 방법 |
| CN103189360A (zh) | 2010-09-01 | 2013-07-03 | 艾尼纳制药公司 | 5-ht2c激动剂的非吸湿性盐 |
| JP6272695B2 (ja) | 2010-09-01 | 2018-01-31 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 体重管理のために有用な５−ｈｔ２ｃアゴニストの改変放出剤形 |
| EP2611449A1 (fr) | 2010-09-01 | 2013-07-10 | Arena Pharmaceuticals, Inc. | Administration de lorcasérine à des individus présentant une insuffisance rénale |
| WO2012030938A1 (fr) | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | Sels de lorcasérine dotés d'acides optiquement actifs |
| UY34436A (es) | 2012-10-09 | 2014-07-31 | Arena Pharm Inc | Metodo de control del peso |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4209630A (en) * | 1976-10-18 | 1980-06-24 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
| US4235911A (en) * | 1979-06-13 | 1980-11-25 | Pfizer Inc. | Hydantoin derivatives |
-
1982
- 1982-04-27 FR FR8207203A patent/FR2525603A1/fr active Granted
-
1983
- 1983-04-08 AT AT0125383A patent/ATA125383A/de not_active IP Right Cessation
- 1983-04-25 DD DD83250187A patent/DD209833A5/de unknown
- 1983-04-25 LU LU84770A patent/LU84770A1/fr unknown
- 1983-04-26 AU AU13953/83A patent/AU1395383A/en not_active Abandoned
- 1983-04-26 JP JP58073687A patent/JPS5910584A/ja active Pending
- 1983-04-26 DK DK183583A patent/DK183583A/da not_active Application Discontinuation
- 1983-04-26 KR KR1019830001753A patent/KR840004428A/ko not_active Application Discontinuation
- 1983-04-26 GR GR71214A patent/GR78481B/el unknown
- 1983-04-26 IL IL68497A patent/IL68497A0/xx unknown
- 1983-04-26 NL NL8301476A patent/NL8301476A/nl not_active Application Discontinuation
- 1983-04-26 ZA ZA832927A patent/ZA832927B/xx unknown
- 1983-04-26 BE BE0/210633A patent/BE896572A/fr not_active IP Right Cessation
- 1983-04-26 PT PT76595A patent/PT76595B/fr unknown
- 1983-04-26 SE SE8302347A patent/SE8302347L/xx not_active Application Discontinuation
- 1983-04-26 IT IT48155/83A patent/IT1167123B/it active
- 1983-04-26 NO NO831473A patent/NO831473L/no unknown
- 1983-04-27 GB GB08311508A patent/GB2133401B/en not_active Expired
- 1983-04-27 DE DE19833315106 patent/DE3315106A1/de not_active Withdrawn
- 1983-04-27 OA OA57984A patent/OA07412A/fr unknown
- 1983-04-27 ES ES521895A patent/ES521895A0/es active Granted
- 1983-04-27 MA MA20003A patent/MA19783A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SE8302347D0 (sv) | 1983-04-26 |
| OA07412A (fr) | 1984-11-30 |
| MA19783A1 (fr) | 1983-12-31 |
| PT76595B (fr) | 1986-01-21 |
| DK183583A (da) | 1983-10-28 |
| LU84770A1 (fr) | 1984-11-28 |
| DE3315106A1 (de) | 1983-11-03 |
| NO831473L (no) | 1983-10-28 |
| GB8311508D0 (en) | 1983-06-02 |
| BE896572A (fr) | 1983-10-26 |
| DK183583D0 (da) | 1983-04-26 |
| FR2525603B1 (fr) | 1984-09-14 |
| SE8302347L (sv) | 1983-10-28 |
| ES8405796A1 (es) | 1984-06-16 |
| GB2133401A (en) | 1984-07-25 |
| DD209833A5 (de) | 1984-05-23 |
| GR78481B (fr) | 1984-09-27 |
| IT8348155A0 (it) | 1983-04-26 |
| IT1167123B (it) | 1987-05-13 |
| NL8301476A (nl) | 1983-11-16 |
| ATA125383A (de) | 1986-05-15 |
| JPS5910584A (ja) | 1984-01-20 |
| AU1395383A (en) | 1983-11-03 |
| ZA832927B (en) | 1984-06-27 |
| FR2525603A1 (fr) | 1983-10-28 |
| KR840004428A (ko) | 1984-10-15 |
| GB2133401B (en) | 1985-10-23 |
| IL68497A0 (en) | 1983-07-31 |
| ES521895A0 (es) | 1984-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2479187B1 (fr) | Procede de preparation de n-octadienol | |
| RO86698A (fr) | Procede pour la preparation des (1-piperidinylalkyle)-pyrhimidinone | |
| RO81944A (fr) | Procede de preparasiton des imidosulfamides | |
| FR2527615B1 (fr) | Procede de preparation du 26,26,26,27,27,27-hexafluoro-1a,25-dihydroxycholesterol | |
| PT76595A (fr) | Procede de preparation de benzoazacycloalkyl-spiro-imidazolidines | |
| RO86511A (fr) | Procede pour la preparation des beta-lactames | |
| FR2555575B1 (fr) | Procede de preparation de 4-alcoxyanilines | |
| RO86646A (fr) | Procede pour la preparation des o0ymethers | |
| RO88128A (fr) | Procede pour preparer n-phosphanomethylglycine | |
| FR2562070B1 (fr) | Procede de preparation de 2-amino-s-triazines | |
| FR2496660B1 (fr) | Procede de preparation de n-acylcarnosine | |
| BE889546A (fr) | Procede de preparation de n-cyclohexylbenzothiazole-2-sulfenamide | |
| FR2534905B1 (fr) | Procede de preparation de phenylcetones | |
| RO88202A (fr) | Procede pour la preparation des spiro-3-heteroazolone | |
| FR2550190B1 (fr) | Procede de preparation de b-phenylserine | |
| PT74559B (fr) | Procede de preparation de trifluoromethylphenyl-tetrahydropyri-dines substituees | |
| FR2528825B1 (fr) | Procede de preparation de meta-chlorobenzotrifluorure | |
| FR2527603B1 (fr) | Procede catalytique de preparation de thio-bis-phenols | |
| RO81430A (fr) | Procede de preparation des azolul siliglycolethers | |
| FR2529889B1 (fr) | Procede de preparation des indoles | |
| FR2526021B1 (fr) | Procede de preparation de 3-hydroxy-benzodiazepinones | |
| FR2550790B1 (fr) | Procede de preparation de la 4-methylionone | |
| FR2493310B1 (fr) | Procede de preparation de thymosine a1 | |
| FR2526790B1 (fr) | Procede de preparation de la o-phenylenediamine | |
| FR2521556B1 (fr) | Procede de preparation de 3, 3'-diamino-diphenylsulfones |